Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada's Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, ...
The March 2026 Top 15 dividend growth stocks list targets high-quality, undervalued companies with a projected 21.28% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results